טוען...
Targeting DNA Mismatches with Rhodium Metalloinsertors
DNA has been exploited as a biological target of chemotherapeutics since the 1940s. Traditional chemotherapeutics, such as cisplatin and DNA-alkylating agents, rely primarily on increased uptake by rapidly proliferating cancer cells for therapeutic effects, but this strategy can result in off-target...
שמור ב:
| הוצא לאור ב: | Inorganica Chim Acta |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061454/ https://ncbi.nlm.nih.gov/pubmed/27746507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ica.2016.01.021 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|